Wallace Advisory Group, LLC Verona Pharma PLC Transaction History
Wallace Advisory Group, LLC
- $124 Billion
- Q3 2025
A detailed history of Wallace Advisory Group, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Wallace Advisory Group, LLC holds 2,384 shares of VRNA stock, worth $254,873. This represents 0.18% of its overall portfolio holdings.
Number of Shares
2,384Holding current value
$254,873% of portfolio
0.18%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
318Shares Held
76.2MCall Options Held
977KPut Options Held
3.12M-
Janus Henderson Group PLC London, X06.13MShares$656 Million0.3% of portfolio
-
Perceptive Advisors LLC New York, NY5.51MShares$589 Million22.87% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y94.13MShares$441 Million16.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million16.88% of portfolio
-
Rtw Investments, LP New York, NY3.05MShares$326 Million4.43% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...